Extraordinary General Meeting in Oncopeptides AB (publ) – Nov 03, 2020
The Pharma Data
NOVEMBER 2, 2020
Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. Rein Piir, Head of Investor Relations at Oncopeptides, E-mail: rein.piir@oncopeptides.com. This information was submitted for publication at 8.00 CET on 3 November 2020. About Oncopeptides.
Let's personalize your content